SYNAGEVA BIOPHARMA CORP's ticker is and the CUSIP is 87159A903. A total of 3 filers reported holding SYNAGEVA BIOPHARMA CORP in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $2,692,000 | +1836.7% | 27,600 | +1740.0% | 0.04% | +2000.0% |
| Q4 2014 | $139,000 | +0.7% | 1,500 | -25.0% | 0.00% | 0.0% |
| Q3 2014 | $138,000 | -27.0% | 2,000 | +11.1% | 0.00% | -33.3% |
| Q2 2014 | $189,000 | -76.8% | 1,800 | -81.6% | 0.00% | -78.6% |
| Q1 2014 | $813,000 | +1706.7% | 9,800 | +1300.0% | 0.01% | +1300.0% |
| Q4 2013 | $45,000 | +650.0% | 700 | +600.0% | 0.00% | – |
| Q3 2013 | $6,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 285 | $1,845,000 | 0.12% |
| GROUP ONE TRADING, L.P. | 700 | $45,000 | 0.00% |
| Citadel Advisors | 5,200 | $337,000 | 0.00% |